Wells Fargo’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Wells Fargo’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-12,779	Closed	-$2.21M	–	6767
2015 Q1	$2.21M	Sell	12,779 -84,205	-87%	-$12.4M	﹤0.01%	2968
2014 Q4	$11.1M	Sell	96,984 -482,268	-83%	-$58.4M	﹤0.01%	1741
2014 Q3	$90.5M	Sell	579,252 -388,910	-40%	-$56.4M	0.04%	476
2014 Q2	$119M	Sell	968,162 -155,348	-14%	-$17.2M	0.05%	419
2014 Q1	$116M	Buy	1,123,510 +16,116	+1%	+$1.65M	0.05%	420
2013 Q4	$99.6M	Buy	1,107,394 +1,032,721	+1,383%	+$82.4M	0.04%	454
2013 Q3	$4.99M	Buy	74,673 +10,566	+16%	+$728K	﹤0.01%	2197
2013 Q2	$4.24M	Buy	+64,107	New	+$3.67M	﹤0.01%	2240

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Wells Fargo's SLXP Position: Q2 2015 in Review

Wells Fargo sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 12,779 shares — an estimated $2.21M sold.

Wells Fargo first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $119M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Wells Fargo reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Wells Fargo sold 12,779 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.21M.
Wells Fargo first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Wells Fargo's SALIX PHARMACEUTICALS LTD DEL position peaked at $119M in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Wells Fargo's 13F filing for Q2 2015, filed 14 Aug 2015.